Valuation (47%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -30.23 | N/A |
PEG Ratio (TTM) | 1.81 | N/A |
P/S Ratio (TTM) | 0.97 | N/A |
P/B Ratio (TTM) | 1.97 | N/A |
P/FCF Ratio (TTM) | 12.42 | N/A |
Price to 5YR AVG Earnings Ratio | -18.58 | N/A |
Price to 5YR AVG FCF Ratio | 217.91 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -3.72% | N/A |
ROE (TTM) | -6.51% | N/A |
Net Profit Margin (TTM) | -3.17% | N/A |
ROIC 5YR AVG | -3.25% | N/A |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -126.80% | -689.95% | -414.82% |
Revenue | 3.16% | 42.82% | 30.37% |
Net Income | -127.68% | -834.04% | -503.98% |
Cash Flow | -15.30% | -30.76% | 1,553.61% |
Health (49%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.61 | N/A |
Quick Ratio (TTM) | 1.78 | N/A |
D/E Ratio (TTM) | 0.20 | N/A |
Interest Coverage (TTM) | -3.65 | N/A |
Piotroski F-Score | 5 | N/A |
Altman Z-Score | 0.90 | N/A |
LTL to 5YR AVG FCF | 30.24 | N/A |
Shares Outstanding Growth 5YR AVG | 11.72% | N/A |